C17, c20, and c21 substituted neuroactive steroids and their methods of use
AssigneeSage Therapeutics, Inc.
InventorsAlbert Jean Robichaud, Gabriel Martinez Botella, Boyd L. Harrison, Francesco G. Salituro, Andrew Griffin, Maria Jesus Blanco-Pillado
Life of this patent
Estimating the term…
Abstract
Described herein are neuroactive steroids or a pharmaceutically acceptable salt thereof. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. Also provided are pharmaceutical compositions comprising a compound described herein and methods of use and treatment, e.g., such as for inducing sedation and/or anesthesia.
Claims21
A compound of Formula (1-A):
- or a pharmaceutically acceptable salt thereof, wherein:
- R3 is alkyl, alkenyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl;
- each of RX and RY is independently hydrogen, aryl, or alkyl
- R19 is hydrogen or alkyl;
- R5 is absent or hydrogen;
- and
- represents a single or double bond, wherein when one is a double bond, the other is a single bond and R5 is absent;
2-68. (canceled)
A compound of Formula (II-c):
- or a pharmaceutically acceptable salt thereof, wherein:
- each of R2, R4, R6, R7, R11a, and R11b is independently hydrogen, halogen, cyano, nitro, alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, heteroaryl, —ORA1, —SRA1, —N(RA1)2, —NHC(═O)RA1, —NHC(═O)ORA1, —S(═O)RA2, —SO2RA2, or —S(═O)2ORA1;
- R3 is alkyl, alkenyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl;
- R5 is absent or hydrogen;
- R19 is hydrogen or alkyl;
- each of R21a and R21b is independently hydrogen, halogen, cyano, nitro, alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, heteroaryl, —ORA1, —SRA1, —N(RA1)2, —NHC(═O)RA1, —NHC(═O)ORA1, —S(═O)RA2, —SO2RA2, or —S(═O)2ORA1;
- or
- R21a and R21b together with the carbon atom to which they are attached form a carbocyclyl, heterocyclyl, or —C(═O)— group;
- Q is —N(RA1)(RA1);
- each instance of RA1 is independently hydrogen, alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, heteroaryl, an oxygen protecting group when attached to an oxygen atom, a sulfur protecting group when attached to a sulfur atom, a nitrogen protecting group when attached to a nitrogen atom, or two RA1 groups are joined to form an heterocyclic or heteroaryl ring;
- RA2 is alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl;
- n is an integer selected from 1, 2, and 3;
- and
- represents a single or double bond, wherein when one is a double bond, the other is a single bond and R5 is absent.
A compound, or pharmaceutically acceptable salt thereof, selected from the group consisting of:
Dependencies are inferred from the claim text.